RINVOQ (Arthritis) TV Commercials

Ad effectiveness starts with the creative, which is why iSpot's Creative Assessment solutions provide fast, actionable insights into the effectiveness and emotional impact of video ads. Brands can objectively measure and benchmark ad performance against competitive and customizable norms while gaining deeper insights through viewer verbatim comments that explain the "why" behind the scores. Using iSpot's Creative Assessment in both pre-market and in-market stages, brands can evaluate creative strengths and weaknesses, make data-driven adjustments, and ultimately improve ad effectiveness while reducing time and spend on creative development.

iSpot empowers advertisers with real-time, second-by-second visibility into every ad across screens, helping optimize media strategies and cut excess frequency and waste. With a robust catalog of over 2.5 million creatives and data from 83 million smart TVs, plus integrations with 400+ streaming platforms and DSPs, iSpot delivers fast, accurate and actionable analytics on both campaign performance and competitor strategies. By measuring impressions, airings, and attention across all viewing environments, advertisers can eliminate blind spots and gain a competitive edge through reliable benchmarking against brands like HUMIRA [Arthritis | Psoriasis], Xeljanz, Enbrel, Orencia, and Celebrex.

iSpot enables advertisers to connect TV and streaming ad exposure directly to key business outcomes like in-store traffic, website visits, and purchases. By mapping campaign data to first- and third-party sources—such as location, intent, sales, and both online and offline conversions—advertisers can avoid wasting spend on ads that don't drive results. iSpot's real-time attribution technology makes it easy to optimize campaigns across platforms for maximum ROAS, ensuring every dollar works harder.